← Open Payments lookup

SYDNEY EGAN: Open Payments

NPI 1396203758 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,195 in 108 payments from 15 companies in 2025. Trend: 2023 $3,195 · 2024 $2,482 · 2025 $2,195

Food & beverage: $2,195
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$346
Otsuka America Pharmaceutical, Inc.17$300
Alkermes, Inc.9$232
Neurocrine BioSciences, Inc.13$230
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$219
Teva Pharmaceuticals USA, Inc.11$217
Supernus Pharmaceuticals, Inc.14$167
Vanda Pharmaceuticals Inc.4$106
ABBVIE INC.5$91
Janssen Pharmaceuticals, Inc3$84

Products named: COBENFY, REXULTI, ARISTADA, INGREZZA, CAPLYTA, Qelbree, AUSTEDO XR, FANAPT.

Industry payments across NV — which companies pay providers there.